Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.73 |
| ▸ | FNTA | P49354 | 2/20 | 0.48 |
| ▸ | FNTB | P49356 | 2/20 | 0.48 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3169682 | 0.92 | ALDH1A1 (0.66) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL3169676 | 0.92 | ALDH1A1 (0.66) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL9953013 | 0.92 | ALDH1A1 (0.66) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL23706455 | 0.89 | ALDH1A1 (0.73) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL31560155 | 0.89 | ALDH1A1 (0.73) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL133908 | 0.87 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL1301765 | 0.87 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL11404530 | 0.87 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL806725 | 0.87 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL11410939 | 0.87 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116322326-B | Polyurea/polyurethane microcapsules | 西姆莱斯股份公司 | 2025-05-02 | — | — | CN | disclosed |
| US-8188241-B2 | Immobilized proteins and methods and uses thereof | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-05-29 | — | — | US | disclosed |
| US-20090069548-A1 | Immobilized Proteins and Methods and Uses Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069548-A1 | Immobilized Proteins and Methods and Uses Thereof | STUB1, MARCKS, SUMO3 | ALDH1A1 3436/4885ALOX15 4706/4885FNTA 183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.